Back to top of page

Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

List of required information for application:

1. Project Title: Provide a clear and concise title for the proposed project.

2. Project Summary: Summarize the objectives, methods, and expected outcomes of the project in a brief and informative manner.

3. Project Timeline: Outline the specific milestones to be accomplished within the 2-year UG3 phase and the subsequent 3-year UH3 phase.

4. Research Plan: Describe in detail the preclinical or clinical research studies that will be conducted to develop medications for opioid and/or psychostimulant use disorders and overdose. Clearly explain how these studies will have a high impact and quickly yield necessary results for FDA approval of the medications.

5. Compound Evaluation: Specify whether the proposed compounds to be evaluated are small molecules or biologics. Clarify if they will be tested in pre-clinical models or for clinical manifestations of opioid use disorders. Outline the specific parameters to be assessed, such as withdrawal, craving, relapse, or overdose.

6. Development Approach: Explain the approach to be taken in the development of medications, which may include the development of new chemical entities, new formulations of marketed medications available for other indications, or combinations of medications.

7. Safety and Efficacy: Provide evidence or a plan for evaluating the safety and efficacy of the medications being developed.

8. Fast-Track Strategy: Describe how the project aims to fast-track the discovery and development of medications to prevent and treat opioid use disorders or opioid overdose.

9. FDA Approval Pipeline: Explain how the project aims to advance the developed medications in the FDA's drug development approval pipeline.

10. Budget: Provide a detailed budget that outlines the anticipated expenses for the entire project period, including personnel, equipment, supplies, and any other costs associated with the research.

11. Research Team: Describe the qualifications and expertise of the principal investigator and the team members involved in the project.

12. Institutional Support: Assure the availability of necessary resources, facilities, and support from the applicant institution to successfully conduct the proposed research.

13. Ethical Considerations: Discuss any ethical considerations related to the proposed research, including human subjects protections, animal welfare, and data sharing.

14. Supervision and Data Management: Explain the plan for supervision, data management, and quality control during the project.

15. Dissemination Plan: Describe how the project outcomes and findings will be disseminated to the scientific community, stakeholders, and the general public.

16. Potential Impact: Explain

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows